Merck (MRK) and Ridgeback Biotherapeutics Provide Update on New Studies of LAGEVRIO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. HOOD
6. QCOM
7. ACN
8. AZN
9. ROIV
10. AAPL

Go back to Merck (MRK) and Ridgeback Biotherapeutics Provide Update on New Studies of LAGEVRIO
Merck & Co. (NYSE: MRK) Delayed: 148.46 -1.87 (1.24%)
Previous Close $150.33    52 Week High $65.46 
Open $148.41    52 Week Low $47.97 
Day High $149.60    P/E 100.99 
Day Low $146.28    EPS $1.47 
Volume 11,187,246